´ëÇѾÏÇÐȸ 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷) : 2023-11-17
±³À°ÀÏÀÚ : 2023-11-17
±³À°Àå¼Ò : ¼¿ï·Ôµ¥È£ÅÚ 2,3Ãþ
±³À°ÁÖÁ¦ : 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ : cancer2@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 400,000¿ø
ºñ°í "1. »çÀüµî·Ï: 1) ȸ¿ø 10¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 20¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 30¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 7¸¸¿ø
2. ÀϹݵî·Ï: 1) ȸ¿ø 20¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 30¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 40¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 10¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 08:30~09:00 AACR Cancer Progress Report 2023 Rajarshi Sengupta(American Association for Cancer Research)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 09:00~09:30 KCA Cancer Report 2023 ±èÅ¿ë(¼¿ïÀÇ´ë)
ÈÞ½Ä 11¿ù 17ÀÏ 09:30~09:40 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 09:40~10:05 Measuring apoptotic priming with BH3 profiling: From laboratory tool to clinical diagnostic Anthony G. Letai(Dana-Farber Cancer Institute, Boston, MA)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:05~10:30 Update of K-MASTER: The first Korean Precision Oncology Initiative ¹Ú°æÈ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:30~10:55 Patient-derived tumor organoid models for functional precision medicine Alice Soragni(University of California, Los Angeles, CA)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:55~11:20 A pragmatic precision medicine platform: KOSMOS trial ±è¼±¿µ(¼¿ï¾Æ»êº´¿ø)
ÈÞ½Ä 11¿ù 17ÀÏ 11:20~11:40 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 11:40~12:20 The cancer dependency map and beyond William C. Hahn(Harvard Medical School, Boston, MA)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 12:30~13:10 Pembrolizumab unveiled: Illuminating its role in esophageal, GEJ and gastric cancer as a shining star in the dark ¾ÈÈ£Á¤(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 11¿ù 17ÀÏ 13:10~13:40 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 13:40~14:05 Exploring the role of telomerase in senescence and exhaustion in CAR T cell immunotherapy Steven Artandi(Stanford Cancer Institute, Stanford, CA)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:05~14:30 Senescent tumor cell; The novel modulator of the cancer microenvironment ¹ÚÅÂÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:30~14:55 Exploiting senescence to treat liver cancer M. Celeste Simon(Abramson Family Cancer Research Institute, Philadelphia, PA)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:55~15:20 The transcriptional hallmarks of oncogene-induced senescence: a combined meta-analysis and machine learning approach ±è¼º¿µ(°Ç±¹ÀÇ´ë)
ÈÞ½Ä 11¿ù 17ÀÏ 15:20~15:40 ÈÞ½Ä ()
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 15:40~16:05 Highly multiplexed imaging for precision breast immuno-oncology Raza Ali(Cancer Research UK, London)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:05~16:30 Dissecting cellular heterogeneity and plasticity of lung cancer ±èÁ¾°æ(POSTECH)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:30~16:55 Understanding plasticity and histological transformation during emergence of resistance to targeted therapies Alvaro Quintanal-Villalonga(Memorial Sloan Kettering Cancer Center, New York, NY)
±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:55~17:20 Anchorage plasticity reconstructs the metastatic cascade ¹ÚÇö¿ì(¿¬¼¼´ë)